Clinical trial
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy and With a PathologIc Complete REsponse After Neoadjuvant Chemotherapy
NCT05866458 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy and With a PathologIc Complete REsponse After Neoadjuvant Chemotherapy
- Lead sponsor
- Ontario Clinical Oncology Group (OCOG)
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 12, 2024
- Completion date
- October 31, 2031
- Enrollment
- 352 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer